Indication
Dabigatran
2 clinical trials
2 products
Clinical trial
A Single Dose, Randomized, Open-label, Two-treatment, Four-period, Two-sequence, Replicate Crossover Bioequivalence Study of Generic Dabigatran Etexilate Capsules 150 mg and Reference Product (Pradaxa®) in Healthy Thai Volunteers Under Fasting Conditions and Under Pre-treatment With a Proton Pump InhibitorStatus: Not yet recruiting, Estimated PCD: 2024-10-08
Product
Dabigatran EtexilateClinical trial
Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study II (IMPACT 2)Status: Not yet recruiting, Estimated PCD: 2026-12-01